| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.00B | 962.51M | 541.65M | 537.99M | 271.99M | 124.23M |
| Gross Profit | 241.36M | 228.57M | 123.56M | 115.94M | 61.92M | 34.20M |
| EBITDA | 189.91M | 163.86M | 77.86M | 89.69M | 22.93M | 20.17M |
| Net Income | 44.33M | 23.26M | 13.53M | 31.24M | -7.56M | 6.51M |
Balance Sheet | ||||||
| Total Assets | 2.23B | 2.15B | 1.02B | 966.93M | 769.32M | 257.22M |
| Cash, Cash Equivalents and Short-Term Investments | 172.77M | 131.36M | 55.87M | 68.62M | 69.92M | 27.45M |
| Total Debt | 671.15M | 641.83M | 238.30M | 262.48M | 233.92M | 71.30M |
| Total Liabilities | 1.45B | 1.39B | 500.38M | 497.08M | 358.16M | 133.66M |
| Stockholders Equity | 748.21M | 724.77M | 500.74M | 458.12M | 400.26M | 123.56M |
Cash Flow | ||||||
| Free Cash Flow | 23.24M | 42.01M | 9.08M | 35.01M | 6.92M | 21.86M |
| Operating Cash Flow | 93.07M | 117.02M | 52.12M | 87.73M | 29.54M | 28.47M |
| Investing Cash Flow | -32.35M | -584.63M | -64.56M | -85.53M | -375.16M | -14.06M |
| Financing Cash Flow | -39.58M | 547.89M | 957.00K | 2.88M | 388.54M | 3.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £1.19B | 13.20 | 7.90% | 4.47% | 7.83% | -7.40% | |
74 Outperform | £1.58B | 35.71 | 6.07% | ― | 32.27% | ― | |
72 Outperform | £77.06M | 14.91 | 5.71% | 5.35% | -0.29% | -33.41% | |
69 Neutral | £378.68M | 24.13 | 7.03% | 2.13% | 15.99% | 96.05% | |
68 Neutral | £400.17M | 16.90 | 3.57% | 4.18% | 1.31% | 10.19% | |
67 Neutral | £513.08M | 42.21 | 3.10% | 2.39% | 5.58% | 66.49% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
SigmaRoc has announced that its Chairman, David Barrett, and Chief Executive, Max Vermorken, have exercised share options granted under the company’s 2016 Share Option Plan on a cashless basis, acquiring 3.9 million and 8.2 million shares respectively through the transfer of beneficial interests from the company’s Employee Benefit Trust. To meet employment tax obligations and provide net proceeds, the trust arranged the sale of 2.8 million Barrett shares and 6.0 million Vermorken shares to institutional investors, leaving Barrett with 5.16 million shares (0.46% of issued capital) and Vermorken with 3.24 million shares (0.29%). The total number of SigmaRoc shares in issue with voting rights remains unchanged at 1,114,854,530, indicating that while the transactions alter insider holdings and signal ongoing use of equity-based remuneration for senior management, they do not affect the company’s overall capital structure or shareholder voting base.
The most recent analyst rating on (GB:SRC) stock is a Buy with a £157.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.
SigmaRoc reported that it expects to beat its 2025 earnings-per-share guidance by around 10%, as underlying EBITDA rose more than 16% to exceed about £262m on revenue of £1.04bn, with margins improving sharply due to cost discipline and synergy delivery from recent UK and Poland acquisitions. Despite softer volumes in construction and steel markets and deliberate volume reductions linked to network optimisation, the group lifted its underlying EBITDA margin to roughly 25%, cut covenant leverage to about 1.8x, and improved ROIC to over 12%, underpinned by achieving its €40m recurring synergy target two years early. Portfolio pruning through the sale of three non-core businesses, the launch of a refinancing to expand funding capacity for future M&A, progress on ESG metrics and kiln decarbonisation, and an active ventures arm all support SigmaRoc’s strategy to consolidate its position in European lime and limestone. Looking into 2026, management signals a cautiously optimistic outlook, expecting benefits from German infrastructure stimulus, a firmer European steel sector, increased defence and green-economy investment, and easing financial conditions, while maintaining a tight focus on costs amid weather and geopolitical risks.
The most recent analyst rating on (GB:SRC) stock is a Hold with a £134.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.